Sinocelltech Ebitda vs Cost Of Revenue Analysis

688520 Stock

39.00 0.62 1.62%

Sinocelltech financial indicator trend analysis is much more than just breaking down Sinocelltech Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sinocelltech Group is a good investment. Please check the relationship between Sinocelltech Ebitda and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sinocelltech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sinocelltech Group Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Sinocelltech's Ebitda and Cost Of Revenue is 0.1. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Sinocelltech Group, assuming nothing else is changed. The correlation between historical values of Sinocelltech's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Sinocelltech Group are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Sinocelltech's Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.1

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Sinocelltech Group income statement and represents the costs associated with goods and services Sinocelltech provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Sinocelltech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sinocelltech Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sinocelltech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 487.3 M

	2021	2022	2023	2024 (projected)
Interest Expense	33.7M	84.5M	111.5M	56.9M
Interest Income	4.7M	3.6M	7.0M	4.2M

Interest Expense Interest Income

Sinocelltech fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Property Plant And Equipment Net	Capital Lease Obligations	Property Plant And Equipment Gross
Total Assets		-0.55	0.95	-0.57	0.79	-0.92	0.77	0.67	0.93	0.3	0.91	0.93	0.95	0.94	0.58	0.97	0.97	0.87	0.96	0.93	0.9	-0.47	0.85	0.88	0.61	0.88
Other Current Liab	-0.55		-0.59	0.72	-0.91	0.74	-0.3	0.02	-0.63	0.46	-0.6	-0.71	-0.49	-0.54	-0.21	-0.57	-0.6	-0.87	-0.45	-0.71	-0.4	0.86	-0.87	-0.7	-0.95	-0.7
Total Current Liabilities	0.95	-0.59		-0.73	0.84	-0.91	0.58	0.44	1.0	0.13	0.97	0.94	0.92	0.97	0.52	0.99	0.96	0.91	0.84	0.94	0.85	-0.65	0.89	0.97	0.71	0.98
Total Stockholder Equity	-0.57	0.72	-0.73		-0.74	0.74	-0.29	0.16	-0.75	0.15	-0.77	-0.65	-0.69	-0.77	-0.56	-0.73	-0.56	-0.81	-0.39	-0.65	-0.4	0.91	-0.82	-0.8	-0.75	-0.8
Net Debt	0.79	-0.91	0.84	-0.74		-0.9	0.42	0.22	0.85	-0.28	0.85	0.93	0.69	0.75	0.32	0.8	0.86	0.97	0.67	0.93	0.72	-0.83	0.94	0.88	0.95	0.88
Retained Earnings	-0.92	0.74	-0.91	0.74	-0.9		-0.72	-0.48	-0.9	-0.15	-0.95	-0.95	-0.91	-0.9	-0.67	-0.93	-0.91	-0.95	-0.87	-0.95	-0.87	0.66	-0.91	-0.87	-0.74	-0.88
Accounts Payable	0.77	-0.3	0.58	-0.29	0.42	-0.72		0.83	0.53	0.69	0.58	0.57	0.82	0.66	0.78	0.68	0.62	0.56	0.89	0.57	0.68	-0.04	0.54	0.43	0.18	0.44
Cash	0.67	0.02	0.44	0.16	0.22	-0.48	0.83		0.39	0.69	0.4	0.47	0.59	0.45	0.42	0.51	0.59	0.29	0.83	0.47	0.71	0.31	0.26	0.26	-0.05	0.27
Non Current Assets Total	0.93	-0.63	1.0	-0.75	0.85	-0.9	0.53	0.39		0.06	0.96	0.94	0.89	0.97	0.48	0.98	0.95	0.92	0.81	0.94	0.81	-0.7	0.91	0.99	0.75	0.99
Non Currrent Assets Other	0.3	0.46	0.13	0.15	-0.28	-0.15	0.69	0.69	0.06		0.14	0.0	0.44	0.27	0.67	0.25	0.11	-0.11	0.46	0.0	0.33	0.53	-0.13	-0.08	-0.53	-0.07
Long Term Debt	0.91	-0.6	0.97	-0.77	0.85	-0.95	0.58	0.4	0.96	0.14		0.95	0.9	0.94	0.62	0.96	0.93	0.89	0.8	0.95	0.89	-0.67	0.85	0.93	0.69	0.94
Common Stock Shares Outstanding	0.93	-0.71	0.94	-0.65	0.93	-0.95	0.57	0.47	0.94	0.0	0.95		0.83	0.87	0.45	0.92	0.98	0.93	0.84	1.0	0.91	-0.66	0.89	0.92	0.79	0.92
Non Current Liabilities Total	0.95	-0.49	0.92	-0.69	0.69	-0.91	0.82	0.59	0.89	0.44	0.9	0.83		0.97	0.78	0.97	0.86	0.83	0.91	0.83	0.81	-0.47	0.82	0.83	0.51	0.84
Inventory	0.94	-0.54	0.97	-0.77	0.75	-0.9	0.66	0.45	0.97	0.27	0.94	0.87	0.97		0.65	0.99	0.89	0.87	0.84	0.87	0.78	-0.61	0.87	0.93	0.62	0.94
Other Current Assets	0.58	-0.21	0.52	-0.56	0.32	-0.67	0.78	0.42	0.48	0.67	0.62	0.45	0.78	0.65		0.63	0.43	0.48	0.61	0.45	0.55	-0.21	0.43	0.39	0.1	0.41
Total Liab	0.97	-0.57	0.99	-0.73	0.8	-0.93	0.68	0.51	0.98	0.25	0.96	0.92	0.97	0.99	0.63		0.94	0.9	0.88	0.92	0.85	-0.6	0.88	0.94	0.65	0.95
Net Invested Capital	0.97	-0.6	0.96	-0.56	0.86	-0.91	0.62	0.59	0.95	0.11	0.93	0.98	0.86	0.89	0.43	0.94		0.89	0.9	0.98	0.93	-0.55	0.85	0.91	0.7	0.92
Short Long Term Debt	0.87	-0.87	0.91	-0.81	0.97	-0.95	0.56	0.29	0.92	-0.11	0.89	0.93	0.83	0.87	0.48	0.9	0.89		0.76	0.93	0.73	-0.82	0.99	0.93	0.9	0.93
Total Current Assets	0.96	-0.45	0.84	-0.39	0.67	-0.87	0.89	0.83	0.81	0.46	0.8	0.84	0.91	0.84	0.61	0.88	0.9	0.76		0.84	0.89	-0.26	0.74	0.72	0.45	0.73
Capital Stock	0.93	-0.71	0.94	-0.65	0.93	-0.95	0.57	0.47	0.94	0.0	0.95	1.0	0.83	0.87	0.45	0.92	0.98	0.93	0.84		0.91	-0.66	0.89	0.92	0.79	0.92
Non Current Liabilities Other	0.9	-0.4	0.85	-0.4	0.72	-0.87	0.68	0.71	0.81	0.33	0.89	0.91	0.81	0.78	0.55	0.85	0.93	0.73	0.89	0.91		-0.32	0.65	0.73	0.47	0.74
Net Working Capital	-0.47	0.86	-0.65	0.91	-0.83	0.66	-0.04	0.31	-0.7	0.53	-0.67	-0.66	-0.47	-0.61	-0.21	-0.6	-0.55	-0.82	-0.26	-0.66	-0.32		-0.82	-0.79	-0.92	-0.79
Intangible Assets	0.85	-0.87	0.89	-0.82	0.94	-0.91	0.54	0.26	0.91	-0.13	0.85	0.89	0.82	0.87	0.43	0.88	0.85	0.99	0.74	0.89	0.65	-0.82		0.93	0.9	0.93
Property Plant And Equipment Net	0.88	-0.7	0.97	-0.8	0.88	-0.87	0.43	0.26	0.99	-0.08	0.93	0.92	0.83	0.93	0.39	0.94	0.91	0.93	0.72	0.92	0.73	-0.79	0.93		0.83	1.0
Capital Lease Obligations	0.61	-0.95	0.71	-0.75	0.95	-0.74	0.18	-0.05	0.75	-0.53	0.69	0.79	0.51	0.62	0.1	0.65	0.7	0.9	0.45	0.79	0.47	-0.92	0.9	0.83		0.82
Property Plant And Equipment Gross	0.88	-0.7	0.98	-0.8	0.88	-0.88	0.44	0.27	0.99	-0.07	0.94	0.92	0.84	0.94	0.41	0.95	0.92	0.93	0.73	0.92	0.74	-0.79	0.93	1.0	0.82

Click cells to compare fundamentals

Sinocelltech Account Relationship Matchups

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Sinocelltech Stock

Balance Sheet is a snapshot of the financial position of Sinocelltech Group at a specified time, usually calculated after every quarter, six months, or one year. Sinocelltech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sinocelltech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sinocelltech currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sinocelltech Ebitda vs Cost Of Revenue Analysis

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Cost Of Revenue

Sinocelltech fundamental ratios Correlations

Sinocelltech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

Other Information on Investing in Sinocelltech Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Current Liabilities
Capital Stock	+ 1.0	Common Stock Shares Outstanding
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Liab	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.99	Non Current Assets Total
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total

Capital Stock	- 0.95	Retained Earnings
Short Long Term Debt	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Long Term Debt	- 0.95	Retained Earnings
Capital Lease Obligations	- 0.95	Other Current Liab
Total Liab	- 0.93	Retained Earnings